Epithelial differentiation and proliferative potential in spinal ependymomas

H. Takeuchi, T. Kubota, K. Sato, J. F. Llena, A. Hirano

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The aim of this investigation eas recognition of the epithelial differentiation and proliferative activity of ependymomas in the spinal cord compared with astrocytomas in the spinal cord and ependymoma in the brain. We investigated histopathological and immunohistochemical examination in thirty-five cases, including eleven ependymomas, thirteen astrocytomas in the spinal region and eleven ependymomas in the intracranial region. An anti-epithelial membrane antigen antibody (EMA), and two types of anti-cytokeratin antibodies, CAM 5.2 (45 and 52 kDa) and keratin (56 and 64 kDa) were applied as epithelial markers. The proliferative potential of the tumors was investigated using the Ki-67 labeling index (LI, %). Histologically, perivascular pseudorosettes were seen in all of the spinal and intracranial ependymomas. There were few ependymal structures in the spinal ependymomas except in the myxopapillary type. Immunohistochemical study demonstrated that nine (82%) were immunoreactive for EMA, eight (73%) were immunoreactive for CAM 5.2 and three (27%) were immunoreactive for keratin in the spinal ependymomas. In the spinal astrocytomas, no tumors were immunoreactive for EMA or CAM 5.2. One of thirteen cases was immunoreactive for keratin. The Ki-67 LI of the spinal ependymomas was lower than that of the intracranial ependymoma (p < 0.01). Epithelial differentiation was found in the ependymomas, which may reflect the differences in histological and biological features between ependymomas and astrocytomas in the spinal cord. Regional differences in ependymomas may influence not only clinical features but also histo-pathological characteristics.

Original languageEnglish (US)
Pages (from-to)13-19
Number of pages7
JournalJournal of Neuro-Oncology
Volume58
Issue number1
DOIs
StatePublished - 2002

Fingerprint

Ependymoma
Astrocytoma
Mucin-1
Keratins
Spinal Cord
Antibodies
Anti-Idiotypic Antibodies
Neoplasms

Keywords

  • Ependymoma
  • Epithelial differentiation
  • Immunohistochemistry
  • Spinal

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Cite this

Epithelial differentiation and proliferative potential in spinal ependymomas. / Takeuchi, H.; Kubota, T.; Sato, K.; Llena, J. F.; Hirano, A.

In: Journal of Neuro-Oncology, Vol. 58, No. 1, 2002, p. 13-19.

Research output: Contribution to journalArticle

Takeuchi, H, Kubota, T, Sato, K, Llena, JF & Hirano, A 2002, 'Epithelial differentiation and proliferative potential in spinal ependymomas', Journal of Neuro-Oncology, vol. 58, no. 1, pp. 13-19. https://doi.org/10.1023/A:1015844704632
Takeuchi, H. ; Kubota, T. ; Sato, K. ; Llena, J. F. ; Hirano, A. / Epithelial differentiation and proliferative potential in spinal ependymomas. In: Journal of Neuro-Oncology. 2002 ; Vol. 58, No. 1. pp. 13-19.
@article{442a0e4a3d6d4d9da1e46fe1d463a22d,
title = "Epithelial differentiation and proliferative potential in spinal ependymomas",
abstract = "The aim of this investigation eas recognition of the epithelial differentiation and proliferative activity of ependymomas in the spinal cord compared with astrocytomas in the spinal cord and ependymoma in the brain. We investigated histopathological and immunohistochemical examination in thirty-five cases, including eleven ependymomas, thirteen astrocytomas in the spinal region and eleven ependymomas in the intracranial region. An anti-epithelial membrane antigen antibody (EMA), and two types of anti-cytokeratin antibodies, CAM 5.2 (45 and 52 kDa) and keratin (56 and 64 kDa) were applied as epithelial markers. The proliferative potential of the tumors was investigated using the Ki-67 labeling index (LI, {\%}). Histologically, perivascular pseudorosettes were seen in all of the spinal and intracranial ependymomas. There were few ependymal structures in the spinal ependymomas except in the myxopapillary type. Immunohistochemical study demonstrated that nine (82{\%}) were immunoreactive for EMA, eight (73{\%}) were immunoreactive for CAM 5.2 and three (27{\%}) were immunoreactive for keratin in the spinal ependymomas. In the spinal astrocytomas, no tumors were immunoreactive for EMA or CAM 5.2. One of thirteen cases was immunoreactive for keratin. The Ki-67 LI of the spinal ependymomas was lower than that of the intracranial ependymoma (p < 0.01). Epithelial differentiation was found in the ependymomas, which may reflect the differences in histological and biological features between ependymomas and astrocytomas in the spinal cord. Regional differences in ependymomas may influence not only clinical features but also histo-pathological characteristics.",
keywords = "Ependymoma, Epithelial differentiation, Immunohistochemistry, Spinal",
author = "H. Takeuchi and T. Kubota and K. Sato and Llena, {J. F.} and A. Hirano",
year = "2002",
doi = "10.1023/A:1015844704632",
language = "English (US)",
volume = "58",
pages = "13--19",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Epithelial differentiation and proliferative potential in spinal ependymomas

AU - Takeuchi, H.

AU - Kubota, T.

AU - Sato, K.

AU - Llena, J. F.

AU - Hirano, A.

PY - 2002

Y1 - 2002

N2 - The aim of this investigation eas recognition of the epithelial differentiation and proliferative activity of ependymomas in the spinal cord compared with astrocytomas in the spinal cord and ependymoma in the brain. We investigated histopathological and immunohistochemical examination in thirty-five cases, including eleven ependymomas, thirteen astrocytomas in the spinal region and eleven ependymomas in the intracranial region. An anti-epithelial membrane antigen antibody (EMA), and two types of anti-cytokeratin antibodies, CAM 5.2 (45 and 52 kDa) and keratin (56 and 64 kDa) were applied as epithelial markers. The proliferative potential of the tumors was investigated using the Ki-67 labeling index (LI, %). Histologically, perivascular pseudorosettes were seen in all of the spinal and intracranial ependymomas. There were few ependymal structures in the spinal ependymomas except in the myxopapillary type. Immunohistochemical study demonstrated that nine (82%) were immunoreactive for EMA, eight (73%) were immunoreactive for CAM 5.2 and three (27%) were immunoreactive for keratin in the spinal ependymomas. In the spinal astrocytomas, no tumors were immunoreactive for EMA or CAM 5.2. One of thirteen cases was immunoreactive for keratin. The Ki-67 LI of the spinal ependymomas was lower than that of the intracranial ependymoma (p < 0.01). Epithelial differentiation was found in the ependymomas, which may reflect the differences in histological and biological features between ependymomas and astrocytomas in the spinal cord. Regional differences in ependymomas may influence not only clinical features but also histo-pathological characteristics.

AB - The aim of this investigation eas recognition of the epithelial differentiation and proliferative activity of ependymomas in the spinal cord compared with astrocytomas in the spinal cord and ependymoma in the brain. We investigated histopathological and immunohistochemical examination in thirty-five cases, including eleven ependymomas, thirteen astrocytomas in the spinal region and eleven ependymomas in the intracranial region. An anti-epithelial membrane antigen antibody (EMA), and two types of anti-cytokeratin antibodies, CAM 5.2 (45 and 52 kDa) and keratin (56 and 64 kDa) were applied as epithelial markers. The proliferative potential of the tumors was investigated using the Ki-67 labeling index (LI, %). Histologically, perivascular pseudorosettes were seen in all of the spinal and intracranial ependymomas. There were few ependymal structures in the spinal ependymomas except in the myxopapillary type. Immunohistochemical study demonstrated that nine (82%) were immunoreactive for EMA, eight (73%) were immunoreactive for CAM 5.2 and three (27%) were immunoreactive for keratin in the spinal ependymomas. In the spinal astrocytomas, no tumors were immunoreactive for EMA or CAM 5.2. One of thirteen cases was immunoreactive for keratin. The Ki-67 LI of the spinal ependymomas was lower than that of the intracranial ependymoma (p < 0.01). Epithelial differentiation was found in the ependymomas, which may reflect the differences in histological and biological features between ependymomas and astrocytomas in the spinal cord. Regional differences in ependymomas may influence not only clinical features but also histo-pathological characteristics.

KW - Ependymoma

KW - Epithelial differentiation

KW - Immunohistochemistry

KW - Spinal

UR - http://www.scopus.com/inward/record.url?scp=0036296938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036296938&partnerID=8YFLogxK

U2 - 10.1023/A:1015844704632

DO - 10.1023/A:1015844704632

M3 - Article

C2 - 12160136

AN - SCOPUS:0036296938

VL - 58

SP - 13

EP - 19

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -